Evidence map›Paper›PMID 39398866›Full record

ArticleJournal of medical imaging (Bellingham, Wash.)2024

Characterization of arteriosclerosis based on computer-aided measurements of intra-arterial thickness.

Jin Zhou, Xiang Li, Dawit Demeke, Timothy A Dinh, Yingbao Yang, Andrew R Janowczyk, Jarcy Zee, Lawrence Holzman, Laura Mariani, Krishnendu Chakrabarty and 3 more

Abstract read
In one paragraph

Article in Journal of medical imaging (Bellingham, Wash.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jin ZhouDuke University, Department of Electrical and Computer Engineering, Durham, North Carolina, United States.ORCID https://orcid.org/0000-0002-7980-7952
Xiang LiDuke University, Department of Electrical and Computer Engineering, Durham, North Carolina, United States.
Dawit DemekeUniversity of Michigan, Department of Pathology, Ann Arbor, Michigan, United States.ORCID https://orcid.org/0009-0002-0905-178X
Timothy A DinhUniversity of Michigan, Department of Pathology, Ann Arbor, Michigan, United States.ORCID https://orcid.org/0000-0002-7601-1756
Yingbao YangUniversity of Michigan, Department of Pathology, Ann Arbor, Michigan, United States.
Andrew R JanowczykGeneva University Hospitals, Department of Oncology, Division of Precision Oncology, Geneva, Switzerland.
Jarcy ZeeUniversity of Pennsylvania, Department of Biostatistics, Epidemiology, and Informatics, Philadelphia, Pennsylvania, United States.ORCID https://orcid.org/0000-0003-0586-1160
Lawrence HolzmanUniversity of Pennsylvania, Department of Medicine, Renal-Electrolyte and Hypertension Division, Philadelphia, Pennsylvania, United States.
Laura MarianiUniversity of Michigan, Department of Internal Medicine, Division of Nephrology, Ann Arbor, Michigan, United States.
Krishnendu ChakrabartyArizona State University, School of Electrical, Computer and Energy Engineering, Tempe, Arizona, United States.ORCID https://orcid.org/0000-0003-4475-6435
Laura BarisoniDuke University, Division of Artificial Intelligence and Computational Pathology, Department of Pathology, Durham, North Carolina, United States.ORCID https://orcid.org/0000-0003-0848-9683
Jeffrey B HodginUniversity of Michigan, Department of Pathology, Ann Arbor, Michigan, United States.
Kyle J LafataDuke University, Department of Electrical and Computer Engineering, Durham, North Carolina, United States.

Funding

The Impact of COVID-19 on People Living with Rare Diseases and Their FamiliesU2CTR002818 · NCATS · CINCINNATI CHILDRENS HOSP MED CTR · PI Michal Kouril · 2019 to 2026
$51.2M
Training Program in Clinical & Translationa Research in Human Glomerular DiseaseU54DK083912 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KRETZLER, MATTHIAS · 2009 to 2023
$20.3M
CureGNU24DK100845 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CRYSTAL A. GADEGBEKU, Laura H Mariani · 2019 to 2026
$12.1M
The Columbia PCC for CureGN: the Cure Glomerulonephropathy networkU01DK100876 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Andrew Stephen Bomback, ALI G GHARAVI · 2019 to 2026
$8.5M
CureGN-Penn PCCU01DK100846 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LAWRENCE B. HOLZMAN · 2019 to 2026
$8.3M
CUREGN 3.0 - Pediatric Nephrology Consortium - PCCU01DK100866 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI Laurence A Greenbaum, Jon Klein · 2019 to 2026
$7.7M
CureGN-3: UNCPCCU01DK100867 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Vimal Kumar Derebail, Ronald J Falk · 2019 to 2026
$6.7M
GDPrimeUM1DK100845 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GIPSON, DEBBIE S, KRETZLER, MATTHIAS · 2013 to 2018
$6.4M
Primary Outcomes in Glomerulonephritis Study (PROGRESS)UM1DK100846 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI HOLZMAN, LAWRENCE B. · 2013 to 2018
$5.8M
Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease BiomarkersUM1DK100866 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI GREENBAUM, LAURENCE A, SMOYER, WILLIAM E · 2013 to 2018
$5.5M
Advancing Clinical Research in Primary Glomerular Diseases (UM1)UM1DK100876 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GHARAVI, ALI G · 2013 to 2018
$4.8M
GDCN Clinical Center-Advancing Clinical Research in Primary Glomerular DiseasesUM1DK100867 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FALK, RONALD J · 2013 to 2018
$4.0M
NCATS NIH HHS U2C TR002818NIDDK NIH HHS R01 DK118431NIDDK NIH HHS U01 DK100846NIDDK NIH HHS U01 DK100866NIDDK NIH HHS U01 DK100867NIDDK NIH HHS U01 DK100876NIDDK NIH HHS U24 DK100845NIDDK NIH HHS U54 DK083912NIDDK NIH HHS UM1 DK100845NIDDK NIH HHS UM1 DK100846NIDDK NIH HHS UM1 DK100866NIDDK NIH HHS UM1 DK100867NIDDK NIH HHS UM1 DK100876NLM NIH HHS R01 LM013864
6 · The paper itself

Abstract

Purpose: Our purpose is to develop a computer vision approach to quantify intra-arterial thickness on digital pathology images of kidney biopsies as a computational biomarker of arteriosclerosis. Approach: The severity of the arteriosclerosis was scored (0 to 3) in 753 arteries from 33 trichrome-stained whole slide images (WSIs) of kidney biopsies, and the outer contours of the media, intima, and lumen were manually delineated by a renal pathologist. We then developed a multi-class deep learning (DL) framework for segmenting the different intra-arterial compartments (training dataset: 648 arteries from 24 WSIs; testing dataset: 105 arteries from 9 WSIs). Subsequently, we employed radial sampling and made measurements of media and intima thickness as a function of spatially encoded polar coordinates throughout the artery. Pathomic features were extracted from the measurements to collectively describe the arterial wall characteristics. The technique was first validated through numerical analysis of simulated arteries, with systematic deformations applied to study their effect on arterial thickness measurements. We then compared these computationally derived measurements with the pathologists' grading of arteriosclerosis. Results: Numerical validation shows that our measurement technique adeptly captured the decreasing smoothness in the intima and media thickness as the deformation increases in the simulated arteries. Intra-arterial DL segmentations of media, intima, and lumen achieved Dice scores of 0.84, 0.78, and 0.86, respectively. Several significant associations were identified between arteriosclerosis grade and pathomic features using our technique (e.g., intima-media ratio average [ Conclusions: We developed a computer vision approach to computationally characterize intra-arterial morphology on digital pathology images and demonstrate its feasibility as a potential computational biomarker of arteriosclerosis.

Indexed as

computerized morphologic assessmentdigital pathologykidney biopsytissue characterization

Identifiers

PMID39398866
PMCPMC11466048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.